$DCTH
Delcath Systems Inc

2017 Q4 Form 10-K Financial Statement

#000156459018005963 Filed on March 16, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2017 Q2
Revenue $704.0K $684.0K $584.0K
YoY Change 4.14% 57.24% 14.29%
Cost Of Revenue $170.0K $170.0K $140.0K
YoY Change -5.56% 54.55% -6.67%
Gross Profit $530.0K $510.0K $449.0K
YoY Change 6.0% 59.38% 24.38%
Gross Profit Margin 75.28% 74.56% 76.88%
Selling, General & Admin $1.880M $2.860M $2.530M
YoY Change -21.99% 21.19% 10.63%
% of Gross Profit 354.72% 560.78% 563.47%
Research & Development $3.380M $2.280M $2.518M
YoY Change 36.84% -15.24% 29.46%
% of Gross Profit 637.74% 447.06% 560.8%
Depreciation & Amortization $110.0K $100.0K $100.0K
YoY Change 37.5% 0.0% 0.0%
% of Gross Profit 20.75% 19.61% 22.27%
Operating Expenses $5.254M $5.139M $5.050M
YoY Change 7.62% 1.82% 19.33%
Operating Profit -$4.725M -$4.627M -$4.601M
YoY Change 7.8% -2.05% 18.86%
Interest Expense $12.50M $5.042M -$6.950M
YoY Change 22.43% 1.59% 488.98%
% of Operating Profit
Other Income/Expense, Net -$50.00K -$2.000K $0.00
YoY Change -99.65% -166.67% -100.0%
Pretax Income -$19.24M -$12.60M -$1.940M
YoY Change 126.62% 1147.52% -70.91%
Income Tax -$140.0K
% Of Pretax Income
Net Earnings -$19.25M -$12.60M -$1.943M
YoY Change 126.8% 1154.58% -70.86%
Net Earnings / Revenue -2733.81% -1841.52% -332.71%
Basic Earnings Per Share -$0.75 -$4.565K -$3.50
Diluted Earnings Per Share -$265.9B -$4.565K -$0.01
COMMON SHARES
Basic Shares Outstanding 2.763K 252.3M
Diluted Shares Outstanding 2.763K 252.3M

Balance Sheet

Concept 2017 Q4 2017 Q3 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.000M $2.500M $1.820M
YoY Change -9.3% -32.25% -75.67%
Cash & Equivalents $3.999M $10.86M $1.816M
Short-Term Investments
Other Short-Term Assets $2.030M $9.220M $14.13M
YoY Change -92.92% -62.43% -23.25%
Inventory $1.248M $1.160M $1.040M
Prepaid Expenses
Receivables $317.0K $300.0K $380.0K
Other Receivables $0.00 $50.00K $0.00
Total Short-Term Assets $7.589M $13.23M $17.37M
YoY Change -77.78% -54.65% -35.67%
LONG-TERM ASSETS
Property, Plant & Equipment $1.298M $1.250M $1.230M
YoY Change 19.85% 9.65% 15.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.298M $1.260M $1.230M
YoY Change 19.85% -83.87% -91.45%
TOTAL ASSETS
Total Short-Term Assets $7.589M $13.23M $17.37M
Total Long-Term Assets $1.298M $1.260M $1.230M
Total Assets $8.887M $14.49M $18.60M
YoY Change -74.78% -60.82% -55.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.846M $1.890M $990.0K
YoY Change 547.47% 950.0% 125.51%
Accrued Expenses $3.408M $2.350M $2.230M
YoY Change 0.03% 22.4% 9.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $490.0K $0.00
YoY Change
Long-Term Debt Due $0.00 $9.740M $12.60M
YoY Change -100.0%
Total Short-Term Liabilities $7.814M $15.89M $17.21M
YoY Change -78.35% -37.42% -48.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $395.0K $444.0K $530.0K
YoY Change -34.6% -36.57% -25.98%
Total Long-Term Liabilities $395.0K $444.0K $530.0K
YoY Change -34.6% -93.76% -25.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.814M $15.89M $17.21M
Total Long-Term Liabilities $395.0K $444.0K $530.0K
Total Liabilities $8.209M $16.34M $17.74M
YoY Change -77.65% -49.72% -50.66%
SHAREHOLDERS EQUITY
Retained Earnings -$324.8M -$305.6M
YoY Change 16.35%
Common Stock $3.000K $14.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K
YoY Change 0.0%
Treasury Stock Shares $1.00 $1.00
Shareholders Equity $678.0K -$1.850M $870.0K
YoY Change
Total Liabilities & Shareholders Equity $8.887M $14.49M $18.60M
YoY Change -74.78% -60.83% -55.06%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2017 Q2
OPERATING ACTIVITIES
Net Income -$19.25M -$12.60M -$1.943M
YoY Change 126.8% 1154.58% -70.86%
Depreciation, Depletion And Amortization $110.0K $100.0K $100.0K
YoY Change 37.5% 0.0% 0.0%
Cash From Operating Activities -$3.740M -$3.520M -$4.320M
YoY Change 3.6% -3.03% 37.14%
INVESTING ACTIVITIES
Capital Expenditures -$150.0K -$90.00K -$220.0K
YoY Change 1400.0% -40.0% 175.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$150.0K -$90.00K -$220.0K
YoY Change 650.0% -47.06% -80.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.790M -14.70M -120.0K
YoY Change -140.04% 16233.33% -105.31%
NET CHANGE
Cash From Operating Activities -3.740M -3.520M -4.320M
Cash From Investing Activities -150.0K -90.00K -220.0K
Cash From Financing Activities -1.790M -14.70M -120.0K
Net Change In Cash -5.680M -18.31M -4.660M
YoY Change -776.19% 370.69% 129.56%
FREE CASH FLOW
Cash From Operating Activities -$3.740M -$3.520M -$4.320M
Capital Expenditures -$150.0K -$90.00K -$220.0K
Free Cash Flow -$3.590M -$3.430M -$4.100M
YoY Change -0.28% -1.44% 33.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8448000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1325000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
317000
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
50000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7589000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1298000
CY2017Q4 us-gaap Assets
Assets
8887000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3408000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9684000
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-15103000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-16440000
CY2017 us-gaap Operating Expenses
OperatingExpenses
20179000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-18165000
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12780000
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9613000
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
138000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
52000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
543000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-95000
CY2017Q4 us-gaap Inventory Net
InventoryNet
1248000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
700000
CY2017Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3846000
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2016Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0625
CY2017 us-gaap Interest Expense
InterestExpense
21703000
CY2016 dcth Loss On Debt Settlements And Extinguishments
LossOnDebtSettlementsAndExtinguishments
0
CY2017 dcth Loss On Debt Settlements And Extinguishments
LossOnDebtSettlementsAndExtinguishments
29924000
CY2015 dcth Loss On Debt Settlements And Extinguishments
LossOnDebtSettlementsAndExtinguishments
0
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-14704000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-216000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10495000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
524000
CY2016 us-gaap Operating Expenses
OperatingExpenses
17882000
CY2015 us-gaap Operating Expenses
OperatingExpenses
16495000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-15210000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-564000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2016 us-gaap Interest Expense
InterestExpense
14328000
CY2015 us-gaap Interest Expense
InterestExpense
67000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17971000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14704000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7006362
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
8601000
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
161000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
266000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1011000
CY2017 dcth Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
2552000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
50000
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
161000
CY2015 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
349000
CY2017 us-gaap Restricted Stock Expense
RestrictedStockExpense
79000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.50
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7019316
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4847
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
18145000
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
308000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8479000
CY2015 dcth Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
176000
CY2015 dcth Fair Value Of Warrants Issued Classified As Liability
FairValueOfWarrantsIssuedClassifiedAsLiability
4247000
CY2015 dcth Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
123000
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
649000
CY2016 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
4435000
CY2016 dcth Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1372000
CY2016 dcth Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
726000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
79000
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
40121000
CY2017 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
4908000
CY2017 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
527000
CY2017 dcth Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
19000
CY2016 us-gaap Restricted Stock Expense
RestrictedStockExpense
266000
CY2015 us-gaap Restricted Stock Expense
RestrictedStockExpense
308000
CY2017 us-gaap Depreciation
Depreciation
310000
CY2016 us-gaap Depreciation
Depreciation
305000
CY2015 us-gaap Depreciation
Depreciation
617000
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-18000
CY2016 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
CY2015 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-15000
CY2017 dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
CY2016 dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
CY2015 dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
21544000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
14268000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-260000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-108000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
420000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3180000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1507000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1757000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-32000
CY2017 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2310000
CY2016 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
30000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-209000
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-220000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15398000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14213000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16420000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
258000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
170000
CY2017 us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
0
CY2016 us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
1087000
CY2015 us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
0
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
180000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-524000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1345000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
10000
CY2017 dcth Increase In Restricted Cash From Financing Activities
IncreaseInRestrictedCashFromFinancingActivities
0
CY2016 dcth Increase In Restricted Cash From Financing Activities
IncreaseInRestrictedCashFromFinancingActivities
26200000
CY2015 dcth Increase In Restricted Cash From Financing Activities
IncreaseInRestrictedCashFromFinancingActivities
0
CY2017 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
13120000
CY2016 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0
CY2015 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
0
CY2017 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2016 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
31226000
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
15000
CY2016 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2383000
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
8655000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15445000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7409000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8655000
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
67000
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-49000
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-107000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-410000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8198000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7862000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12607000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20469000
CY2017 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
40121000
CY2016 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
649000
CY2015 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
16953000
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
28472000
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
4247000
CY2017 dcth Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
2537000
CY2016 dcth Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0
CY2015 dcth Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0
CY2017 dcth Deemed Dividend Amount
DeemedDividendAmount
527000
CY2016 dcth Deemed Dividend Amount
DeemedDividendAmount
0
CY2015 dcth Deemed Dividend Amount
DeemedDividendAmount
0
CY2017 dcth Fair Value Of Warrants Exercised For Cash
FairValueOfWarrantsExercisedForCash
19000
CY2016 dcth Fair Value Of Warrants Exercised For Cash
FairValueOfWarrantsExercisedForCash
726000
CY2015 dcth Fair Value Of Warrants Exercised For Cash
FairValueOfWarrantsExercisedForCash
123000
CY2017 us-gaap Basis Of Accounting
BasisOfAccounting
<div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Basis of Consolidated Financial Statement Presentation</p></td></tr></table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accounting and financial reporting policies of the Company conform to generally accepted accounting principles in the United States of America (GAAP). The preparation of consolidated financial statements in conformity with GAAP requires management to make assumptions and estimates that impact the amounts reported in the Company&#8217;s consolidated financial statements. The consolidated financial statements include the accounts of all entities controlled by Delcath. All significant inter-company accounts and transactions are eliminated.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&nbsp;</p></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company&#8217;s consolidated balance sheets and the amount of revenues and expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, the accounting for derivative instrument liabilities, stock-based compensation, valuation of inventory, impairment of long-lived assets, income taxes and operating expense accruals. Such assumptions and estimates are subject to change in the future as additional information becomes available or as circumstances are modified. Actual results could differ from these estimates.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p></div>
CY2017 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:5%;">Deferred Revenue</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;margin-left:5%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue on the accompanying consolidated balance sheets includes payment received for product sales to a distributor. When obligations or contingencies remain after the products are shipped, such as training and certifying the treatment centers, revenue is deferred until the obligations or contingencies are satisfied. The Company will recognize the revenue related to product sales when its obligations under the agreement have been satisfied.</p></div>
CY2017 dcth Maximum Period Of Investments With Original Maturities From Date Of Acquisition To Be Cash Equivalents
MaximumPeriodOfInvestmentsWithOriginalMaturitiesFromDateOfAcquisitionToBeCashEquivalents
P3M
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45644000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20791
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3463
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
298000
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
346000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
721000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
214000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
229000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
100000
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
421000
CY2016Q4 us-gaap Prepaid Insurance
PrepaidInsurance
501000
CY2017Q4 dcth Financing Costs Current
FinancingCostsCurrent
70000
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
50000
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
50000
CY2017Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
159000
CY2016Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
147000
CY2017Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2016Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5174000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4886000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3876000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3803000
CY2017Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
869000
CY2016Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
1365000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1124000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
933000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
221000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
286000
CY2017Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
209000
CY2016Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
216000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
985000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
607000
CY2017Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2016Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2017Q4 dcth Debt Instrument Extended Prepayment Date
DebtInstrumentExtendedPrepaymentDate
2018-03-31
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
126.00
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
112.00
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
70.00
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
49.00
CY2017Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
38.50
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
21.00
CY2017Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
17.50
CY2017Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
17.50
CY2017Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
24.50
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1478318
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
544000
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3045817
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
125999
CY2017Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
4417829
CY2017Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3621286
CY2017Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1913915
CY2017Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
2000000
CY2017Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1015848
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
35000000
CY2017Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-21000000
CY2016Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
234
CY2013Q4 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
7500000
CY2013Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6900000
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
440
CY2015Q1 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
2600000
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2500000
CY2015Q3 us-gaap Partners Capital Account Units Sale Of Units
PartnersCapitalAccountUnitsSaleOfUnits
1670
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1670
CY2015Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000
CY2016Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1215
CY2016Q4 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
1200000
CY2016Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1100000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
51
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
94
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
136
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
48
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
88
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
42
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
127
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
75
CY2015 dcth Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price Per Share
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePricePerShare
6664
CY2017 dcth Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price Per Share
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePricePerShare
84.00
CY2017 dcth Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Exercise Price Per Share
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodExercisePricePerShare
6664.00
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
132328.00
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6664.00
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
168056.00
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42840.00
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8382.50
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12815.73
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
84.00
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6664.00
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8750.55
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13882.03
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M29D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y11M12D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M14D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
101
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
45
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
114
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
25
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
13
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
2
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
52
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7892.50
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
9397.50
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
6730.50
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6686.40
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
84
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6707.08
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
6664.00
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1349.38
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6800
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
23600
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
152
CY2015 dcth Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
3120
CY2015 dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
39
CY2015 dcth Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
8
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3224
CY2016 dcth Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
20091
CY2016 dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
1428
CY2016 dcth Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
1271
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
20616
CY2017 dcth Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
7127551
CY2017 dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
122848
CY2017 dcth Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
19367
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7005952
CY2014Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
30341.76
CY2015 dcth Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
4480.00
CY2015 dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
4592.00
CY2015 dcth Class Of Warrant Or Right Weighted Average Exercise Price Expirations In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExpirationsInPeriod
4592.00
CY2015Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
5607.33
CY2016 dcth Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
1680.00
CY2016 dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
963.00
CY2016 dcth Class Of Warrant Or Right Weighted Average Exercise Price Expirations In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExpirationsInPeriod
1988.00
CY2016Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
1820.00
CY2017 dcth Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
4.60
CY2017 dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
8.44
CY2017 dcth Class Of Warrant Or Right Weighted Average Exercise Price Expirations In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExpirationsInPeriod
1690.50
CY2017Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
3.14
CY2014 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y9M11D
CY2015 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P2Y1M28D
CY2016 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P5Y7M2D
CY2017 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P4Y10M17D
CY2017 dcth Number Of Inputs Used For Valuation Of Warrants
NumberOfInputsUsedForValuationOfWarrants
6
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
225000
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
564000
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
123000
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3785000
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
12780000
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
726000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
18751000
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
15103000
CY2017 dcth Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Extinguishment Gain Loss Of Convertible Note Warrant
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExtinguishmentGainLossOfConvertibleNoteWarrant
17489000
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
2552000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
560000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
872000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
501000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
456000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
281000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2110000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-41313000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13930000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14704000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
15340000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6110000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4999000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-143000
CY2017 dcth Income Tax Reconciliation Nondeductible Expense Interest
IncomeTaxReconciliationNondeductibleExpenseInterest
-6912000
CY2017 dcth Income Tax Reconciliation Loss On Extinguishment Of Debt
IncomeTaxReconciliationLossOnExtinguishmentOfDebt
-10174000
CY2017 dcth Income Tax Rate Reconciliation Federal Operating Loss Carryforwards
IncomeTaxRateReconciliationFederalOperatingLossCarryforwards
-5067000
CY2016 dcth Income Tax Rate Reconciliation Federal Operating Loss Carryforwards
IncomeTaxRateReconciliationFederalOperatingLossCarryforwards
-68795000
CY2017 dcth Income Tax Rate Reconciliation State Operating Loss Carryforwards
IncomeTaxRateReconciliationStateOperatingLossCarryforwards
-1373000
CY2016 dcth Income Tax Rate Reconciliation State Operating Loss Carryforwards
IncomeTaxRateReconciliationStateOperatingLossCarryforwards
-13891000
CY2017 dcth Income Tax Reconciliation Federal Tax Credits
IncomeTaxReconciliationFederalTaxCredits
324000
CY2016 dcth Income Tax Reconciliation Federal Tax Credits
IncomeTaxReconciliationFederalTaxCredits
4023000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
-767000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
-767000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
-767000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1339000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2576000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-380000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-11276000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-3804000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4040000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-3428000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-45117000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17970000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1196000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1141000
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-920000
CY2017 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Costs And Expenses
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToCostsAndExpenses
-1423000
CY2016 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Costs And Expenses
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToCostsAndExpenses
-75407000
CY2015 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Costs And Expenses
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToCostsAndExpenses
2649000
CY2017 dcth Income Tax Reconciliation Derivative Charge
IncomeTaxReconciliationDerivativeCharge
8403000
CY2016 dcth Income Tax Reconciliation Derivative Charge
IncomeTaxReconciliationDerivativeCharge
4345000
CY2015 dcth Income Tax Reconciliation Derivative Charge
IncomeTaxReconciliationDerivativeCharge
192000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-841000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-53000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-674000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
295000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
250000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
199000
CY2017 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-3000
CY2016 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-18000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
292000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1386000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1279000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
353000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
343000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
633000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
17000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
22000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3796000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
34000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
55000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
66000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5289000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6194000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
77906000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5985000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8000000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
83680000
CY2016Q4 dcth Deferred Income Tax Liabilities Beneficial Conversion Feature
DeferredIncomeTaxLiabilitiesBeneficialConversionFeature
906000
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
13000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
906000
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5972000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7094000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
83680000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q4 dcth Valuation Allowance Deferred Tax Asset Percentage
ValuationAllowanceDeferredTaxAssetPercentage
1.00
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1100000
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-76600000
CY2016 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Additional Paid In Capital
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToAdditionalPaidInCapital
-1854000
CY2016 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Retained Earnings
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToRetainedEarnings
1010000
CY2017 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Other Comprehensive Income
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToOtherComprehensiveIncome
301000
CY2016 dcth Valuation Allowance Deferred Tax Asset Change In Amount Charged To Other Comprehensive Income
ValuationAllowanceDeferredTaxAssetChangeInAmountChargedToOtherComprehensiveIncome
-335000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 dcth Tax Cuts And Jobs Act Of2017 Tax Effect Accounting Complete
TaxCutsAndJobsActOf2017TaxEffectAccountingComplete
false
CY2017 dcth Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Assets Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetsProvisionalIncomeTaxExpenseBenefit
-143500
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
743000
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
584000
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
684000
CY2017Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
704000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4736000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
5050000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
5139000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
5254000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4212000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4601000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4627000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4725000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-11332000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1943000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-12596000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-19246000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-87.50
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.50
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.36
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
370000
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
511000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
435000
CY2016Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
676000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
3721000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
4232000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
5047000
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
4882000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3462000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3871000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4724000
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4383000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1813000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-6667000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1004000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-8486000
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-437.50
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1543.50
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-230.99
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1292.02

Files In Submission

Name View Source Status
0001564590-18-005963-index-headers.html Edgar Link pending
0001564590-18-005963-index.html Edgar Link pending
0001564590-18-005963.txt Edgar Link pending
0001564590-18-005963-xbrl.zip Edgar Link pending
dcth-10k_20171231.htm Edgar Link pending
dcth-20171231.xml Edgar Link completed
dcth-20171231.xsd Edgar Link pending
dcth-20171231_cal.xml Edgar Link unprocessable
dcth-20171231_def.xml Edgar Link unprocessable
dcth-20171231_lab.xml Edgar Link unprocessable
dcth-20171231_pre.xml Edgar Link unprocessable
dcth-ex231_8.htm Edgar Link pending
dcth-ex311_6.htm Edgar Link pending
dcth-ex312_9.htm Edgar Link pending
dcth-ex321_7.htm Edgar Link pending
dcth-ex322_10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018031613302662113910.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending